Total submissions: 4
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV000197297 | SCV000250879 | likely pathogenic | not provided | 2015-06-19 | criteria provided, single submitter | clinical testing | p.Ser236Phe (S236F) (TCT>TTT): c.707 C>T in exon 4 of the TGFBR1 gene (NM_004612.2) The S236F variant that is likely pathogenic in the TGFBR1 gene has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. The S236F variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Additionally, the S236F variant is a non-conservative amino acid substitution occurring within the protein kinase domain, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Furthermore, multiple missense mutations in nearby residues (K232E, F234L, S241L, E245G) have been reported in association with aortic aneurysm and Loeys-Dietz syndrome and Shprintzen-Goldberg syndrome, supporting the functional importance of this region of the protein. Therefore, this variant is a strong candidate for a pathogenic mutation, however the possibility that it is a benign variant cannot be excluded. This variant was found in TAADV2-PANCARD |
| ARUP Laboratories, |
RCV000507920 | SCV000605369 | uncertain significance | not specified | 2016-08-04 | criteria provided, single submitter | clinical testing | |
| Blueprint Genetics | RCV000197297 | SCV000927814 | likely pathogenic | not provided | 2018-07-19 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV002363012 | SCV002664021 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2020-03-02 | criteria provided, single submitter | clinical testing | The p.S236F variant (also known as c.707C>T), located in coding exon 4 of the TGFBR1 gene, results from a C to T substitution at nucleotide position 707. The serine at codon 236 is replaced by phenylalanine, an amino acid with highly dissimilar properties, and is located in the protein kinase domain. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |